|
|
CORPORATE
ANNOUNCEMENTS:
Glenmark molecule phase I trials
Glenmark Pharmaceuticals Ltd said that its prospective neuropathic pain, osteoarthritis and other inflammatory pain disorders molecule — GRC 10693 — has completed Phase I trials in Europe. The study was conducted on 80 healthy ...
RESTRUCTURING:
Strides to hive off R&D, sterile products entities
Bangalore, April 13 In a recast of its global operations, Strides Arcolab Ltd has announced plans to carve out two new subsidiaries, one for R&D and the other for specialty or ...
MERGERS & ACQUISITIONS:
Zuari Industries hikes stake in Texmaco to 21%
Move to steer clear of crossholdings. Kolkata, April 13 Mr S.K. Poddar, son-in-law of late K K Birla, who controls Texmaco, has taken steps to steer the company clear of ...
NEW PRODUCTS & SERVICES:
Small cities, towns make beeline for Nano
Mumbai, April 13 Bookings for the Nano continued in many parts of the country despite holidays on account of Good Friday and Easter ...
OUTLOOK:
Tebma Shipyards to go slow on capacity expansion
Chennai, April 13 The Chennai-headquartered Tebma Shipyards Ltd is going slow on its capacity expansion programme though it is “not affected by economic ...
MERGERS & ACQUISITIONS:
Pfizer to raise stake in Indian arm
Mumbai, April 13 Multinational drug-major Pfizer Inc is set to increase its indirect stake in the Indian subsidiary to 75 per cent, from the present 41 per cent, in what is being seen as a consolidation prior to its integration with ...
ACCOUNTING STANDARDS:
Lanco Infra appoints joint auditors
Lanco Infratech has appointed Brahmayya & Co as joint auditor for the company books of accounts for the year 2008-09. With this move, Brahmayya & Co would now serve as joint auditors along with Price Waterhouse, who were the ...
Columnists:
C Gopinath
Harish Bijoor
Ramanujam Sridhar
Radhika Chada
K Srikrishna
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|